Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Performing phase I clinical trials of anticancer agents: perspectives from within the European union and JapanMartin D Forster, Nagahiro Saijo, Lesley Seymour, et al.Nature Communications|March 18, 2023
Cumulative burden of 144 conditions, critical care hospitalisation and premature mortality across 26 adult cancersWai Hoong Chang, Richard D Neal, Martin D Forster, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 23, 2007
Flow cytometric method for determining folate receptor expression on ovarian carcinoma cellsMartin D Forster, Michael G Ormerod, Roshan Agarwal, et al.Cancer Medicine|September 28, 2021
Evidence to guide the optimal timing for pre-chemotherapy blood tests for early breast, colorectal cancer and diffuse large B-cell lymphomaPinkie Chambers, Li Wei, Martin D Forster, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 18, 2019
Patient factors and their impact on neutropenic events: a systematic review and meta-analysisPinkie Chambers, Yogini Jani, Li Wei, et al.European Journal of Cancer (Oxford, England : 1990)|October 25, 2019
Patritumab or placebo, with cetuximab plus platinum therapy in recurrent or metastatic squamous cell carcinoma of the head and neck: A randomised phase II studyMartin D Forster, Magnus T Dillon, Judit Kocsis, et al.ESC Heart Failure|July 23, 2024
Use of heart failure medical therapy before and after a cancer diagnosis: A longitudinal studyChengsheng Ju, Wallis C Y Lau, Charlotte Manisty, et al.BMC Cancer|August 12, 2020
Immunotherapy and associated immune-related adverse events at a large UK centre: a mixed methods studyLiz Jamieson, Martin D Forster, Kam Zaki, et al.Eclinicalmedicine|January 15, 2026
Survivin recombinant overlapping peptide (ROP) vaccine in advanced solid tumours: a first-in-human, multicentre, open-label, phase 1a dose-escalation studyWynne Wijaya, Thomas Morris, Martin D Forster, et al.JCO Oncology Practice|March 12, 2020
Understanding Molecular Testing Uptake Across Tumor Types in Eight Countries: Results From a Multinational Cross-Sectional SurveyPinkie Chambers, Kenneth K C Man, Vivian W Y Lui, et al.Pageof 6